Oncology Today with Dr Neil Love - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Oncology Today with Dr Neil Love — Health & Fitness
Oncology Today with Dr Neil Love

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Latest Episodes:

Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma Sep 27, 2023

Show notes

Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

Novel Agents and Strategies in the Treatment of Ovarian Cancer Sep 25, 2023

Show notes

Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors Sep 22, 2023

Show notes

Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

Optimizing the Management of Metastatic Pancreatic Cancer Sep 15, 2023

Show notes

Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma Sep 13, 2023

Show notes

Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

Meet The Professor: Optimizing the Management of Melanoma Sep 11, 2023

Show notes

Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy Sep 08, 2023

Show notes

Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the future of care for patients with this disease, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma Sep 05, 2023

Show notes

Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer Sep 01, 2023

Show notes

Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here

Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma Aug 30, 2023

Show notes

Featuring a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love.

CME information and select publications here.

Related Podcasts